Stemline Therapeutics Announces ELZONRIS Clinical Data Selected for Presentation at Upcoming EHA Annual Congress

NEXT STORY
Bioxytran Using Paradigm Changing Vital Sign that Can Measure Real Time Tissue Oxygen Balance in Emergency Medicine
PREV STORY
“Global mRNA Vaccines and Therapeutics Market Set to Grow to $5.5bn by 2024”, according to Visiongain
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Health Canada approval of low-dose colchicine for cardiovascular disease based on the COLCOT study

author_avatar
NASDAQ Market News

Black Diamond Therapeutics Announces FDA Allowance of IND Application for BDTX-1535, A MasterKey Inhibitor of EGFR for the Treatment of Gliobastoma and Non-Small Cell Lung Cancer

author_avatar
NASDAQ Market News

Immune Design to Host June 4 Cancer Immunotherapy Event in Chicago and Present at Jefferies 2018 Global Healthcare Conference in New York

SEATTLE and SOUTH SAN FRANCISCO, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- Immune Design ...

author_avatar
NASDAQ Market News